首页> Haematologica> <i>CDKN2A</i> deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS).

<i>CDKN2A</i> deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS).

导出 OA

翻译打印收藏纠错

第一作者： Francesco,Maura

第一单位： Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Weill Cornell Medical College, New York, NY.

作者： Francesco,Maura ^[1] ; Anna,Dodero ^[2] ; Cristiana,Carniti ^[2] ; Niccolò,Bolli ^[3] ; Martina,Magni ^[2] ; Valentina,Monti ^[4] ; Antonello,Cabras ^[4] ; Daniel,Leongamornlert ^[5] ; Federico,Abascal ^[5] ; Benjamin,Diamond ^[6] ; Bernardo,Rodriguez-Martin ^[7] ; Jorge,Zamora ^[7] ; Adam,Butler ^[5] ; Inigo,Martincorena ^[5] ; Jose M C,Tubio ^[7] ; Peter J,Campbell ^[5] ; Annalisa,Chiappella ^[8] ; Giancarlo,Pruneri ^[9] ; Paolo,Corradini ^[10]

作者单位： Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire, United Kingdom; Weill Cornell Medical College, New York, NY. ^[1] Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan. ^[2] Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan. ^[3] Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan. ^[4] The Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, Cambridgeshire. ^[5] Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. ^[6] CIMUS - Molecular Medicine and Chronic Diseases Research Centre, University of Santiago de Compostela. ^[7] Present address: Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Department of Hematology Azienda Ospedaliera Città della Salute e della Scienza, Turin. ^[8] Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan. ^[9] Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan. paolo.corradini@unimi.it. ^[10]